CN101869221B - Feed additive for improving reproductive capacity of sow and preparation method thereof - Google Patents
Feed additive for improving reproductive capacity of sow and preparation method thereof Download PDFInfo
- Publication number
- CN101869221B CN101869221B CN2010101955026A CN201010195502A CN101869221B CN 101869221 B CN101869221 B CN 101869221B CN 2010101955026 A CN2010101955026 A CN 2010101955026A CN 201010195502 A CN201010195502 A CN 201010195502A CN 101869221 B CN101869221 B CN 101869221B
- Authority
- CN
- China
- Prior art keywords
- sow
- vitamin
- percent
- feed additive
- rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001850 reproductive effect Effects 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000003674 animal food additive Substances 0.000 title abstract description 13
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 32
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 28
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960000304 folic acid Drugs 0.000 claims abstract description 16
- 235000019152 folic acid Nutrition 0.000 claims abstract description 16
- 239000011724 folic acid Substances 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 14
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 14
- 239000011719 vitamin A Substances 0.000 claims abstract description 14
- 229940046009 vitamin E Drugs 0.000 claims abstract description 14
- 229940045997 vitamin a Drugs 0.000 claims abstract description 14
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 11
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 11
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000018905 epimedium Nutrition 0.000 claims abstract description 11
- 239000010457 zeolite Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims abstract description 4
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 9
- 241000110637 Cuscuta chinensis Species 0.000 claims description 9
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 9
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 6
- 240000007890 Leonurus cardiaca Species 0.000 claims description 4
- 230000012173 estrus Effects 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 18
- 238000000034 method Methods 0.000 abstract description 16
- 241000207925 Leonurus Species 0.000 abstract description 7
- 239000000654 additive Substances 0.000 abstract description 5
- 230000000996 additive effect Effects 0.000 abstract description 5
- 210000000582 semen Anatomy 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 2
- 241000893536 Epimedium Species 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 20
- 239000003814 drug Substances 0.000 description 15
- 239000003595 mist Substances 0.000 description 11
- 238000009395 breeding Methods 0.000 description 8
- 230000000857 drug effect Effects 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 230000001488 breeding effect Effects 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 210000001672 ovary Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 241000424773 Epimedium alpinum Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 235000014590 basal diet Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940124301 concurrent medication Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000008011 embryonic death Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002596 lutein cell Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a feed additive for improving the reproductive capacity of a sow. The feed additive comprises the following raw materials in percentage by weight: 45 to 50 percent of epimedium, 10 to 15 percent of leonurus, 5 to 10 percent of semen cuscutae, 5 to 10 percent of angelica sinensis, 3 to 5 percent of safflower, 0.3 to 0.5 percent of vitamin A, 1 to 2 percent of vitamin E, 0.5 to 0.8 percent of folic acid and the balance of zeolite powder. The invention also discloses a preparation method for the feed additive. The method comprises the following steps of: mixing the epimedium, the leonurus, the semen cuscutae, the angelica sinensis and the safflower; smashing a mixture to a particle size of between 25 and 40 microns; adding the vitamin A, the vitamin E, the folic acid and the zeolite powder; and mixing uniformly. The feed additive prepared by the method has the characteristics of less additive amount and quick response when in use, and can remarkably improve the oestrus rate and the conception rate of the sow, and has no toxic or side effect.
Description
Technical field
The present invention relates to a kind of feed addictive, particularly relate to a kind of feed addictive that improves reproductive capacity of sow and preparation method thereof.
Background technology
The Along with people's growth in the living standard; People constantly increase for pork consumption demand amount, must increase the supply of live pig through increasing sow quantity, infer according to present sow variety breeding performance of raising and sow livestock on hand quantity; The live pig supply should be greater than demand now; Yet true really not so, the not enough present situation of cut of pork often appearred in recent years, and pork holds at high price; Here except eqpidemic disease reason (death rate is high) and nutrition reason (production performance fails to bring into play fully), lowly closely related with sow production capacity.
Sow production capacity is low, and it is low mainly to show as the rate of oestrusing, and the breeding success rate is low, and litter size is few, causes the breed decrease in efficiency.According to investigations, purebred ratio with hybridization virgin sow out of heat is about about 30% and 20% more than 9 monthly ages, and it is out of heat even up to more than 50% more than 9 monthly ages that the virgin sow is hybridized on the pig farm that has; Postpartum is purebred to be respectively about 25% and 20% with the crossbreeding sow back ratio out of heat more than 10 days that weans, and is respectively about 10% and 5% above ratio out of heat more than 30 days.The pig farm that has reach postpartum 40～50 days time still some sow can not normally oestrus, increased nonproductive fate greatly, the nonproductive fate on the pig farm that has even reach more than 100 days has reduced the sow economic use value; The conception rate of sow of breeding simultaneously is about 70%, if these present situations can not get effective improvement, will bring about great losses for aquaculture.Want to improve farrow in sow year nest number and nest litter size; We will start with from sow with functions of promoting sexual maturity; By means of suitable technique and product, of the right age breeding virgin sow or the long-term wean sow that does not oestrus are oestrused as early as possible, impel its symptom of estrus obvious; And improve sow number of eggs ovulated and conception rate, increase sow year litter size.
Most researchers thinks that the main cause of the weary feelings of sow is relevant with the sex hormone secretion deficiency, and most manual works lures the feelings method to achieve the goal through the injection hormone.Hormone commonly used has pregnant mare serum gonadotrop(h)in (PMSG) (PMSG), estrogen and tristeronum compositum, but PMSG makes ovary produce anovular large follicle easily, because the PMSG long half time, can cause sow out of heat for a long time after luring the feelings failure, forfeiture reproductive capacity; Estrogen regular meeting influences the normality cycle of sow, uses estrogen to lure the sow great majority of feelings failure in considerable time, can't recover normally to oestrus; Tristeronum compositum can make the oestrus of sow rate reach more than 80%, but the breeding conception rate has only (weary feelings sow manual work lures the research and the commentary of feelings method, Wang Zukun, Heilungkiang animal reproduction, the 4th phase, 2000) about 20%.It is thus clear that injection hormone method effect is unstable, can not correctly regulate the endocrine of sow, does not have the effect that lures feelings.
For this reason, part scholar changes the research thinking, sets about utilizing Chinese herbal medicine to impel oestrus of sow, has obtained certain effect.Chinese herb feed additive have promote growth, prevent disease, the function such as prevent miscarriage of promoting the sexual maturity, use the back to the animals and animal product noresidue, have no side effect, be difficult for developing immunity to drugs.From the modern nutriology theory analysis, contained alkaloid, polysaccharide, glucoside, volatile fatty acid, organic acid etc. all are bioactivators in the Chinese herbal feed additive, with being impregnated good action are arranged to promoting oestrus of sow.The scholar is arranged, and (hormone and Chinese herbal and crude drugs preparations are to the effect and the contrast test of sow atypical estrus, and Huang is ignorant, Chinese animal and veterinary; The 7th phase; 2006) utilize the Chinese herbal treatment sow to lack feelings,, exist that addition height, drug effect are slow, waste is serious and problems such as palatability difference though obtained certain effect; Thereby cause pig to produce few food or food refusal behavior, do not reach desirable effect.
Summary of the invention
The invention provides the Chinese herbal medicine composite feed additive that a kind of addition is few, drug effect also can obviously improve oestrus of sow rate and conception rate soon.
A kind of feed addictive that improves reproductive capacity of sow, its raw material weight percentage consists of:
Barrenwort 45～50%
Motherwort 10～15%
The seed of Chinese dodder 5～10%
Radix Angelicae Sinensis 5～10%
Safflower 3～5%
Vitamin A 0.3～0.5%
Vitamin E 1～2%
Folic acid 0.5～0.8%
All the other are zeolite powder.
Preferably, its raw material weight percentage consists of:
Barrenwort 45～50%
Motherwort 10～15%
The seed of Chinese dodder 10%
Radix Angelicae Sinensis 10%
Safflower 5%
Vitamin A 0.5%
Vitamin E 2%
Folic acid 0.8%
All the other are zeolite powder.
Barrenwort: warm in nature, flavor is hot, sweet, returns liver, kidney channel, has kidney-replenishing, strengthing aitch bone, and the wet effect of dispeling the wind is used to treat impotence and seminal emission, coils diseases such as the atrophic debility of bones is soft, arthralgia due to wind-dampness, numbness contracture.
Motherwort: cool in nature, bitter is returned liver, pericardium channel, has the effect of invigorate blood circulation, dispel silt, menstruation regulating, the water that disappears, and can treat irregular menstruation, threatened abortion difficult labour, and placenta retension, postpartum anemic fainting, abdominal pain due to blood stasis, metrorrhagia and metrostaxis, rushes down blood, diseases such as the swollen sore of carbuncle at hematuria.
The seed of Chinese dodder: warm in nature, it is sweet to distinguish the flavor of, and returns liver, kidney channel, have nourishing liver and kidney, the controlling nocturnal emission with astringent drugs urine that contracts, antiabortive, make eye bright, the effect of antidiarrheal cures mainly impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness and weakness of waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, fetal irritability, spleen and suffers from a deficiency of the kidney and rush down.
Radix Angelicae Sinensis: warm in nature, it is sweet, hot to distinguish the flavor of, and returns liver, the heart, the spleen channel; Having enriches blood invigorates blood circulation; Menstruction regulating and pain relieving, the effect that relaxes bowel cures mainly sallow, the dizzy palpitaition of the deficiency of blood, irregular menstruation, through closing dysmenorrhoea, asthenia cold abdominalgia, the dry constipation of intestines, arthralgia due to wind-dampness, injury from falling down, ulcer sores.
Safflower: warm in nature, flavor is hot, and the thoughts of returning home, Liver Channel have the effect of the latus rectum of invigorating blood circulation, blood stasis removing analgesic, cure mainly through close, dysmenorrhoea, lochia are not all right, abdominal mass lump in the abdomen, traumatic injury.
Above-mentioned Chinese medicine all can be selected from the commercially available prod.
Vitamin A can be selected the vitamin A micro-capsule of 500,000 IU/ gram for use.
Vitamin E can be selected 50% vitamin E powder for use.
It is 99% folic acid that folic acid can be selected purity for use.
The fineness of zeolite powder is 80～120 orders, uses as carrier.
Said vitamin and zeolite powder all can be selected from the commercially available prod.
Vitamin A, E, folic acid etc. all are the important nutrient that ovum forms.When sow is deficient in vitamin A, conception rate can occurs and descend, show as undesired, the difficult labour of oestrusing, miscarriage, stillborn foetus, weak tire, monster and retention of afterbirth; Sow pig then shows as the delay of oestrusing, influences the development of ovary, and rate of embryonic death is high.Suitably improve the addition of diet vitamin A, can improve sow nest litter size and number pigs weaned.Vitamin E and reproductive capability are closely related, can promote the generation of thyroid-stimulating hormone and corticotropin and promoting sexual gland hormone, strengthen the ovary function; Make ovarian follicle increase lutein cell, replenishing vitamins E in the sow daily ration can not only improve conception rate; Reduce foetal death, increase the nest litter size, and can strengthen the anti-stress ability of piglet; Piglet is dead before reducing wean, shortens sow and weans to inter oestrual period.Research shows, the sow nest litter size of the high-level vitamin E of feeding, to produce the young number of living all higher, and mammitis-hysteritis-agalactia syndrome (MMA) incidence of disease is lower.The ovary function descends when sow is deficient in vitamin E, and sexual cycle is unusual, can not be fertilized the unusual or appearance of embryonic development.Folic acid has important effect to the reproductive performance of keeping sow with promotion fetus early development.Its major function is the coenzyme in various different enzyme systems, participates in the synthetic of purine, so quite important to synthesizing of DNA, RNA.Keeping aspect the Steady breed function of broad sow, can improve the nest litter size; Keep good lactation power, prevent that lactation is disorderly.The sow daily ration adds folic acid can improve embryo survival, the stable nest litter size that improves.When lacking folic acid, stillborn foetus can appear.
More than all medicine coordination linkages, sow is oestrused as early as possible, promote ovulation to be impregnated simultaneously.Use the back and improve the sow sexual desire, impel the characteristic of oestrusing obvious, can safeguard the health of sow body, promote reproductive organs tissue development and reparation, promote reproduction and immunity function, improve ovum quality and number of eggs ovulated, improve conception rate, reduce the feelings rate of returning.
Feed addictive of the present invention in use, it adds according to ratio of percentage by weight 0.08～0.12% in feed.
The preparation method of above-mentioned feed addictive; Comprise: with percentage by weight is that 45～50% barrenwort, 10～15% motherwort, 5～10% the seed of Chinese dodder, 5～10% Radix Angelicae Sinensis and 3～5% safflower mix; Being crushed to particle diameter is 25～40 microns; Adding percentage by weight is 0.3～0.5% vitamin A, 1～2% vitamin E, 0.5～0.8% folic acid and zeolite powder, mixes.
Broken being meant with the biological cell broken wall of cell grade micro mist is the comminution process of purpose, and it is not purpose with the smashing fineness, but pursues the sporoderm-broken rate of cell.Broken through the cell grade micro mist, can the fineness of former green material be brought up to more than 300 orders from 40～80 orders of traditional handicraft, for general medicinal material, the breaking-wall cell rate under this fineness condition is greater than 95%.Cell intracellular active ingredient behind broken wall fully comes out, the rate of release and the burst size of medicine can significantly improve.The medicinal material particle is after the cell grade micro mist is broken, and microscopically is observed only has the minute quantity intact cell to exist.The cell grade micro mist is broken to mainly contain following advantage aborning: (1) increases the drug absorption rate, improves the Chinese traditional medicine biology utilization rate: after Chinese medicine cell grade micro mist is broken, the main pharmacodynamics composition of medicine be distributed in usually in the cell with cytoplasm in, and being main in the cell.Active ingredient comes out in its cell behind the breaking-wall cell, so drug effect increases substantially, and onset speed is fast; (2) help the retains biological activity composition; Improve drug effect: in the broken process of cell grade micro mist; Do not produce superheating phenomenon through control, even can under low-temperature condition, carry out, and pulverizing speed is fast; Help keeping the bioactive ingredients and the various nutritional labeling of non-refractory like this, thereby improve drug effect; (3) conservation, be convenient to use: Chinese medicine can use the dosage littler than former prescription medicine under the situation that obtains same curative effect after the cell grade micro mist is broken.General medicine can no longer pass through processing such as lixiviate, decoction after the cell grade micro mist is broken, reduced loss of active ingredients in the production link, has maximally utilised raw material, so this technology is suitable for the pulverizing of rare Chinese medicine, and owing to the increase of fineness.Can improve mouthfeel, be convenient to take.On the other hand, be in totally-enclosed dustless system, to carry out because of the cell grade micro mist is broken, can effectively avoid outside contamination, make the content of microorganisms of product and dust content be able to control.
Beneficial effect of the present invention is embodied in:
(1) Chinese herbal medicine composite feed additive of the present invention can obviously improve oestrus of sow rate and conception rate;
(2) Chinese herbal medicine composite feed additive of the present invention, addition is few in use, and effective.Problems such as have in the traditional Chinese medicine interpolation process that adding proportion is high, cost is high, drug effect is slow, waste is serious and process technology is improper; And adopt the broken technology of cell grade micro mist that effective ingredient is directly come out; Improve the absorption and the bioavilability of medicine greatly, shortened the drug effect time.Not only reduce addition but also reduce cost definite effect simultaneously.
(3) Chinese herbal medicine composite feed additive of the present invention, has no side effect at noresidue.Used additive mostly contains the antibiotic, hormone of chemical synthesis etc. in the conventional feed, and secondary residual harm humans is healthy thereby these compositions very easily cause poison, pollution of ecological environment.And in feed, add feed addictive of the present invention; All adopt non-harmful natural Chinese medicinal herb and vitamin; Do not add any chemical synthesis antiseptic and poisonous and harmful substance, do not produce the cross-resistance of people and animals' concomitant medication, thoroughly avoided the secondary residual drawback of conventional feed poisoning.
The specific embodiment
Feed addictive herbal raw material of the present invention is purchased in Anhui Province Bozhou City letter Li De pharmaceutcal corporation, Ltd.
Embodiment 1
Respectively barrenwort, motherwort, the seed of Chinese dodder, Radix Angelicae Sinensis and safflower are dried, weighing barrenwort 450 grams, motherwort 100 grams, the seed of Chinese dodder 100 restrain respectively then, Radix Angelicae Sinensis 100 restrains, safflower 50 grams, section arrangement then; Mix, mixed mixture is at first carried out 60 order coarse crushings, it is broken to adopt QYF type fluidized bed air flow crusher to carry out the cell grade micro mist then; It is 25～40 microns (approximately fineness is 350～500 orders) that mixture is crushed to average grain diameter; And the vitamin A micro-capsule 5 that adds 500,000 IU/ gram again restrains 50% vitamin E powder, 20 grams, 99% folic acid 8 grams; Add carrier zeolite powder (fineness is 100 orders) again; Total amount reaches 1000 grams, mixes once more, promptly obtains feed addictive of the present invention.
Embodiment 2
Identical with embodiment 1 method; The weight of the raw material that adds is respectively: vitamin A micro-capsule 5 grams of barrenwort 500 grams, motherwort 150 grams, the seed of Chinese dodder 100 grams, Radix Angelicae Sinensis 100 grams, safflower 50 grams, 500,000 IU/ gram; 50% vitamin E powder, 20 grams; 99% folic acid 8 grams are according to preparing the Chinese herbal medicine composite feed additive with embodiment 1 identical preparation method.
Embodiment 3
Identical with embodiment 1 method; The weight of the raw material that adds is respectively: vitamin A micro-capsule 5 grams of barrenwort 450 grams, motherwort 150 grams, the seed of Chinese dodder 100 grams, Radix Angelicae Sinensis 100 grams, safflower 50 grams, 500,000 IU/ gram; 50% vitamin E powder, 20 grams; 99% folic acid 8 grams are according to preparing the Chinese herbal medicine composite feed additive with embodiment 1 identical preparation method.
Application examples 1
Test place: the just flat plant in Xiaoshan, Hangzhou.
Test period: the test since on July 20th, 2008, September 2 in 2008 end of day, 44 days experimental periods,, wherein 22 days is feed period.
The selection of test pig and grouping: select physique healthy and strong, more than the body weight 120kg, passed through 48 of the replacement gilts of growing up of not oestrusing as yet of the age in days of oestrusing, be divided into 2 processed group at random, each processed group is established 3 repetitions, and each repeats 8.
Basal diet prescription and nutrient content: as shown in table 1.
The test daily ration: the additive that utilizes embodiment 1 to prepare is that 0.1% consumption substitutes 0.1% zeolite powder in the basal ration prescription as the test daily ration according to percentage by weight.
Table 1
Annotate: contain in every kilogram of feed: the rope A 12000IU that supports one's family, vitamin D 1500IU; 45 milligrams of vitamin Es, vitamin K
32 milligrams, Cobastab
12 milligrams, Cobastab
26 milligrams, Cobastab
120.025 milligram, 0.2 milligram of biotin, 4 milligrams in folic acid, 25 milligrams in pantothenic acid, 50 milligrams in nicotinic acid; 5 milligrams of Cu, 75 milligrams of Zn, 80 milligrams of Fe, 10 milligrams of Mn, 0.25 milligram of Se, 0.3 milligram of I, 500 milligrams in choline, 300 milligrams in 15% aureomycin; Wherein DE, Lys, Met+Cys and Thr are calculated value, and all the other are measured value; Wherein, the additive that compound premix is made up of trace element and amino acid etc. can adopt commercially available product.
Test pig breeding method: adopt conventional artificial insemination method to breed.
Process of the test is handled and data acquisition: perform estrus induction, semen deposition, write down a number of oestrusing.The test feed that sow after the semen deposition is stopped using and promotes the sexual maturity changes the gestation material of feeding special into.Conception rate is added up in the judgement (do not return feelings as confining spectrum in 18-24 days with the back of breeding usually in the production, this test was not returned feelings as confining spectrum in back 24 days to breed) of being impregnated, and the record data such as effect of being impregnated.
Data: adopt SPSS (16.0) that data are handled, and carry out one-way analysis of variance and least significant difference method (LSD) check.Data are represented with average.
Test result:
(1) add feed addictive of the present invention to oestrus of sow to influence the result as shown in table 2:
Table 2
Visible by table 2, test group oestrus of sow rate has improved 87.52% (p＜0.01) than control group.
(2) add feed addictive of the present invention to sow be impregnated to influence the result as shown in table 3:
Table 3
Can know that by table 3 test group sow conception rate has improved 28% (p＜0.05) than control group.
Can be known that by above-mentioned test data in the sow daily ration, behind the interpolation feed addictive of the present invention, compare with control group, test group oestrus of sow rate has improved 87.52% (p＜0.01), conception rate has improved 28% (p＜0.05).Show that adding feed addictive of the present invention has obvious effects to improving reproductive capacity of sow.
Application examples 2
Test period: the test since on August 15th, 2009, September 28 in 2009 end of day, feed period 44 days, wherein 22 days is feed period.
Test place: with application examples 1.
The selection of test pig and grouping: select physique healthy and strong; Often occur postpartum out of heat or that the post-partum estrus unclear symptoms shows, or feelings often appear returning and or inter oestrual period surpass 10 days; Grow up 60 of multiparity sows are divided into 2 processed group at random, and each processed group is established 3 repetitions; Each repeats 10, the two kinds of feeds of feeding respectively.The feed preparation is the same with processing.
The test daily ration: the additive that utilizes embodiment 2 to prepare is that 0.1% consumption substitutes 0.1% zeolite powder in the basal ration prescription as the test daily ration according to percentage by weight.
Basal diet, test pig breeding method, process of the test processing and data acquisition and data processing method are with application examples 1.
Test result:
(1) add feed addictive of the present invention to oestrus of sow to influence test result as shown in table 4:
Table 4
Visible by table 4, test group oestrus of sow rate has improved 47.04% (p＜0.01) than control group.
(2) add feed addictive of the present invention to sow be impregnated to influence test result as shown in table 5:
Table 5
Can know that by table 5 test group sow conception rate has improved 11.72% (p＜0.05) than control group.
Can be known that by above-mentioned test data in the sow daily ration, behind the interpolation feed addictive of the present invention, compare with control group, test group oestrus of sow rate has improved 47.04% (p＜0.01), conception rate has improved 11.72% (p＜0.05).Show that adding feed addictive of the present invention has obvious effects to the reproductive capacity of sow that improves through postpartum.
Claims (3)
1. feed addictive that improves reproductive capacity of sow, its raw material weight percentage consists of:
2. feed addictive according to claim 1 is characterized in that, described raw material weight percentage consists of:
3. the preparation method of feed addictive as claimed in claim 1; Comprise: with percentage by weight is that 45～50% barrenwort, 10～15% motherwort, 5～10% the seed of Chinese dodder, 5～10% Radix Angelicae Sinensis and 3～5% safflower mix; Being crushed to particle diameter is 25～40 microns; Adding percentage by weight is 0.3～0.5% vitamin A, 1～2% vitamin E, 0.5～0.8% folic acid and zeolite powder, mixes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101955026A CN101869221B (en) | 2010-06-08 | 2010-06-08 | Feed additive for improving reproductive capacity of sow and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101955026A CN101869221B (en) | 2010-06-08 | 2010-06-08 | Feed additive for improving reproductive capacity of sow and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101869221A CN101869221A (en) | 2010-10-27 |
| CN101869221B true CN101869221B (en) | 2012-07-25 |
Family
ID=42994451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101955026A Expired - Fee Related CN101869221B (en) | 2010-06-08 | 2010-06-08 | Feed additive for improving reproductive capacity of sow and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101869221B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077927B (en) * | 2010-12-15 | 2012-09-05 | 河南雄峰科技有限公司 | Chinese herbal medicinal additive for stock boar and concentrate feed containing same |
| CN102239973A (en) * | 2011-08-15 | 2011-11-16 | 赣州八维生物科技有限公司 | Additive used for nursing sows, preparation process and using method thereof |
| CN102783585B (en) * | 2012-08-30 | 2014-04-16 | 山东新希望六和集团有限公司 | Feed for improving reproductive performance of sows |
| CN105124266A (en) * | 2015-09-06 | 2015-12-09 | 泗洪县东盛家畜养殖有限公司 | Chinese herbal medicine additive capable of increasing ovulation rate of sows |
| CN105379979A (en) * | 2015-11-22 | 2016-03-09 | 衡阳市富矿饲料添加剂有限公司 | Chinese herbal medicine additive capable of prolonging productive life of breeding sow and preparation method thereof |
| CN106070018A (en) * | 2016-06-17 | 2016-11-09 | 安徽省农业科学院畜牧兽医研究所 | Small-fat-tail sheep ewe and the hybridization of Australia Baigong sheep produce Australia and tremble with fear the method for three generations ram |
| CN106538863A (en) * | 2016-11-04 | 2017-03-29 | 湖北博大生物股份有限公司 | A kind of organic composite and its feedstuff for promoting replacement gilt heat |
| CN108077578A (en) * | 2017-12-29 | 2018-05-29 | 常德惠生九鼎食品有限公司 | It is a kind of for the Chinese medicine composition of postpartum sow and feed and preparation method thereof |
| CN108740445A (en) * | 2018-06-29 | 2018-11-06 | 郭林超 | A kind of feed for the feed addictive and its preparation improving reproductive capacity of sow |
| CN112314526A (en) * | 2020-11-22 | 2021-02-05 | 日喀则市鼎峰养殖有限责任公司 | Breeding method for improving reproductive capacity of plateau sows |
| CN115463170B (en) * | 2022-08-23 | 2023-07-25 | 沈阳农业大学 | Traditional Chinese medicine composition and feed additive for promoting oestrus of livestock and poultry as well as preparation method and application of traditional Chinese medicine composition and feed additive |
| CN115531439B (en) * | 2022-11-24 | 2024-02-02 | 河南招财生物工程有限公司 | Solid emulsion for promoting sow oestrus and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695482A (en) * | 2005-06-16 | 2005-11-16 | 湖南广安生物技术有限公司 | Additive of feedstuff for promoting oestrus of sow |
| CN1733138A (en) * | 2005-08-10 | 2006-02-15 | 范明国 | Medicine for curing animal barrenness |
-
2010
- 2010-06-08 CN CN2010101955026A patent/CN101869221B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695482A (en) * | 2005-06-16 | 2005-11-16 | 湖南广安生物技术有限公司 | Additive of feedstuff for promoting oestrus of sow |
| CN1733138A (en) * | 2005-08-10 | 2006-02-15 | 范明国 | Medicine for curing animal barrenness |
Non-Patent Citations (3)
| Title |
|---|
| 胡元亮."菟丝子"、"红花".《中药饲料添加剂的开发与应用》.化学工业出版社,2005,(第1版),第158-159页、第163-164页. |
| 赵红梅.中药超微粉碎在饲料工业生产中的应用.《饲料研究》.2008,(第3期),第14-17页. * |
| 邵彩梅等.猪营养研究最新进展摘要.《养猪》.1997,(第4期),第11页右栏倒数第1-4行. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101869221A (en) | 2010-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869221B (en) | Feed additive for improving reproductive capacity of sow and preparation method thereof | |
| CN101669587B (en) | Boar nutrition replenisher and preparation method thereof | |
| CN102488105B (en) | Health care feed additive for farrowing sows and preparation method thereof | |
| CN106071224A (en) | A kind of Chinese herbal feed additive for improving sow lactogenic reproductive performance and preparation method thereof | |
| CN103005170B (en) | Chinese medicinal herb compound feed additive for preventing and treating postpartum hypogalactia of sow | |
| CN101869222A (en) | Feed additive for improving reproductive capacity of boar and preparation method thereof | |
| CN101589772B (en) | Chinese herbal medicine feed additive for fattening cattle and application thereof | |
| CN106386694A (en) | Culture method of stocking yellow cattle | |
| CN106376751A (en) | Sow feed and breeding method thereof | |
| CN101268809A (en) | Compound premix for pregnancy sow | |
| CN101869225B (en) | Feed additive for improving pregnancy rate of sows and preparation method thereof | |
| CN105146228A (en) | Chinese herb compound preparation used for sow miscarriage prevention and preparing method thereof | |
| CN101731456A (en) | 1% compound premix special for foxes and raccoon dogs | |
| CN102239973A (en) | Additive used for nursing sows, preparation process and using method thereof | |
| ES2389252T3 (en) | Method to improve the fertility of animals with indole-3-acetic acid | |
| CN104920822B (en) | A kind of parent population feed and its compound method containing spirulina powder | |
| CN103721008A (en) | Traditional Chinese medicine veterinary drug for treating out of heat of livestock and preparation method of traditional Chinese medicine veterinary drug | |
| CN106578519A (en) | Feed for increasing milk yield of sow and preparing method thereof | |
| CN106578484A (en) | Chinese herbal medicine feed supplement for sows in suckling period | |
| CN104855741A (en) | Feed for promoting estrus and pregnancy for female forest musk deer and method for breeding female forest musk deer | |
| CN106342753B (en) | A kind of expanding propagation method of beef cattle | |
| CN104491649B (en) | A kind of Chinese medicine preparation for promoting oestrus of sow to improve farrowing rate and lactagogue function | |
| CN112273549A (en) | Vitamin premix for breeding pigs and preparation method thereof | |
| CN106135647A (en) | A kind of feed additive being conducive to shortening sow stages of labor | |
| Mirzaei et al. | Influence of a dietary phytoadditive on the performance of does and respective litters in cross bred dairy goats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20180608 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |